Europe Rotavirus Vaccine Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Rotavirus Vaccine Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Pentavalent Oral Market Performance (Volume)
  • 2.1.2 Oral Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Pentavalent Oral Market Performance (Value)
  • 2.1.2 Oral Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Government Institution Market Performance (Volume)
  • 3.1.2 Private Sector Market Performance (Volume)
  • 3.1.3 Other Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Astellas Pharma
  • 4.1.1 Astellas Pharma Profiles
  • 4.1.2 Astellas Pharma Product Information
  • 4.1.3 Astellas Pharma Rotavirus Vaccine Business Performance
  • 4.1.4 Astellas Pharma Rotavirus Vaccine Business Development and Market Status
• 4.2 CSL Limited
  • 4.2.1 CSL Limited Profiles
  • 4.2.2 CSL Limited Product Information
  • 4.2.3 CSL Limited Rotavirus Vaccine Business Performance
  • 4.2.4 CSL Limited Rotavirus Vaccine Business Development and Market Status
• 4.3 Emergent BioSolutions
  • 4.3.1 Emergent BioSolutions Profiles
  • 4.3.2 Emergent BioSolutions Product Information
  • 4.3.3 Emergent BioSolutions Rotavirus Vaccine Business Performance
  • 4.3.4 Emergent BioSolutions Rotavirus Vaccine Business Development and Market Status
• 4.4 GlaxoSmithKline
  • 4.4.1 GlaxoSmithKline Profiles
  • 4.4.2 GlaxoSmithKline Product Information
  • 4.4.3 GlaxoSmithKline Rotavirus Vaccine Business Performance
  • 4.4.4 GlaxoSmithKline Rotavirus Vaccine Business Development and Market Status
• 4.5 Johnson&Johnson
  • 4.5.1 Johnson&Johnson Profiles
  • 4.5.2 Johnson&Johnson Product Information
  • 4.5.3 Johnson&Johnson Rotavirus Vaccine Business Performance
  • 4.5.4 Johnson&Johnson Rotavirus Vaccine Business Development and Market Status
• 4.6 MedImmune
  • 4.6.1 MedImmune Profiles
  • 4.6.2 MedImmune Product Information
  • 4.6.3 MedImmune Rotavirus Vaccine Business Performance
  • 4.6.4 MedImmune Rotavirus Vaccine Business Development and Market Status
• 4.7 Merck
  • 4.7.1 Merck Profiles
  • 4.7.2 Merck Product Information
  • 4.7.3 Merck Rotavirus Vaccine Business Performance
  • 4.7.4 Merck Rotavirus Vaccine Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 Europe Rotavirus Vaccine Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Europe Rotavirus Vaccine Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Europe Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Europe Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Germany Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Germany Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Germany Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 UK Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 UK Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 UK Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 France Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 France Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 France Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Russia Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Russia Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Russia Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Benelux Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Benelux Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Benelux Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Italy Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Italy Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Italy Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Spain Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Spain Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Spain Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Europe Rotavirus Vaccine Market Performance (Sales Point)

• 7.1 Europe Rotavirus Vaccine Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Europe Rotavirus Vaccine Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Europe Rotavirus Vaccine Price (USD/Unit) by Regions 2013-2018
• 7.4 Europe Rotavirus Vaccine Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Europe Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Germany Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 UK Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 France Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Russia Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Benelux Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Italy Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Government Institution Industry
• 11.2 Private Sector Industry
• 11.3 Other Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Europe Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Europe Rotavirus Vaccine Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Germany Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 UK Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 France Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Russia Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Benelux Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Italy Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Spain Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Pentavalent Oral Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Oral Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Government Institution Sales and and Growth Rate 2019-2024
  • 12.4.3 Private Sector Sales and and Growth Rate 2019-2024
  • 12.4.4 Other Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Europe Rotavirus Vaccine Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Europe Rotavirus Vaccine Gross Profit Trend 2019-2024

13 Conclusion